ad45ef9793507121…
StudyID:
NCT00018278761 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response. |
| completionDate | 2001-09 |
| conditions | ["Alzheimer Disease"] |
| enrollmentCount | null |
| enrollmentType | null |
| nctId | NCT00018278 |
| phase | PHASE4 |
| sponsorId | us-department-of-veterans-affairs |
| startDate | 1998-10 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease |
| url | https://clinicaltrials.gov/study/NCT00018278 |
Canonical JSON
{
"id": "NCT00018278",
"type": "Study",
"data": {
"briefSummary": "The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.",
"completionDate": "2001-09",
"conditions": [
"Alzheimer Disease"
],
"enrollmentCount": null,
"enrollmentType": null,
"nctId": "NCT00018278",
"phase": "PHASE4",
"sponsorId": "us-department-of-veterans-affairs",
"startDate": "1998-10",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease",
"url": "https://clinicaltrials.gov/study/NCT00018278"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:ad45ef9793507121ddf09eafc793b868d94f9eeca4ee70f1624b038d7f37f3a9